Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial
- PMID: 10473477
- PMCID: PMC28214
- DOI: 10.1136/bmj.319.7210.612
Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial
Abstract
Objectives: To evaluate two different methods of improving adherence to antidepressant drugs.
Design: Factorial randomised controlled single blind trial of treatment leaflet, drug counselling, both, or treatment as usual.
Setting: Primary care in Wessex
Participants: 250 patients starting treatment with tricyclic antidepressants.
Main outcome measures: Adherence to drug treatment (by confidential self report and electronic monitor); depressive symptoms and health status.
Results: 66 (63%) patients continued with drugs to 12 weeks in the counselled group compared with 42 (39%) of those who did not receiving counselling (odds ratio 2.7, 95% confidence interval 1.6 to 4.8; number needed to treat=4). Treatment leaflets had no significant effect on adherence. No differences in depressive symptoms were found between treatment groups overall, although a significant improvement was found in patients with major depressive disorder receiving drug doses of at least 75 mg (depression score 4 (SD 3.7) counselling v 5.9 (SD 5.0) no counselling, P=0.038).
Conclusions: Counselling about drug treatment significantly improved adherence, but clinical benefit was seen only in patients with major depressive disorder receiving doses >/=75 mg. Further research is required to evaluate the effect of this approach in combination with appropriate targeting of treatment and advice about dosage.
Figures
Comment in
-
Antidepressant drugs have previously been shown to be ineffective in mild depression.BMJ. 2000 Jan 29;320(7230):311. BMJ. 2000. PMID: 10650036 Free PMC article. No abstract available.
References
-
- Robins LN, Helzer JE, Weismann MM, Orvaschel H, Gruenberg E, Burke JD, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiat. 1984;41:949–958. - PubMed
-
- Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press; 1996.
-
- Goldberg DP, Bridges K. Invited review: somatic presentations of psychiatric illness in primary care setting. J Psychosom Res. 1988;32:137–144. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical